Amorepacific Corp.

DUBLIN, Nov. 20, 2023 /PRNewswire/ -- The "Ginseng - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. Global Ginseng Market to Reach $17.7 Billion by 2030 The global market for Ginseng estimated at US$8 Billion in the year 2022, is projected to reach a revised size of US$17.7 Billion by 2030, growing at a CAGR of 10.4% over the analysis period 2022-2030. The analysis delves into specific ginseng types such as Asian Ginseng and American Ginseng, as well as various end-uses, including supplements, personal care, and other applications. These insights aid in understanding market dynamics, growth prospects, and industry trends in the ginseng market. Asian Ginseng, one of the segments analyzed in the report, is projected to record 10.1% CAGR and reach US$11 Billion by the end of the analysis period. Growth in the American Ginseng segment is estimated at 10.8% CAGR for the next 8-year period. The U.S. Market is Estimated at $423.9 Million, While China is Forecast to Grow at 12.2% CAGR The Ginseng market in the U.S. is estimated at US$423.9 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$6.3 Billion by the year 2030 trailing a CAGR of 12.2% over the analysis period 2022 to 2030. It provides independent assessments of annual sales figures in US$ Thousand for the years 2022 through 2030, along with corresponding percentage Compound Annual Growth Rates (CAGRs). Additionally, it includes historical data, spanning the years 2014 to 2021, and presents a 16-year perspective with a breakdown of value sales percentages for select years (2014, 2023, and 2030). Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7.5% and 8.8% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 8.4% CAGR. What`s New? Special discussions on the global economic climate and market sentiment Coverage on global competitiveness and key competitor percentage market shares Market presence analysis across multiple geographies - Strong/Active/Niche/Trivial Online interactive peer-to-peer collaborative bespoke updates Access to digital archives and trademarked research platform Complimentary updates for one year Access to curated YouTube video transcripts of market sentiments shared by CEOs, domain experts and market influencers via interviews, podcasts, press statements and event keynotes MARKET OVERVIEW Ginseng - Global Key Competitors Percentage Market Share in 2022 (E) Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E) COVID-19 Pandemic Leads to Increased Consumer Focus on Health and Wellness Products Pandemic Increases Consumer Demand for Healthier Ingredients in Foods and Beverages COVID-19 Brings Forth Enormous Opportunities for Adaptogens Potential Role of Ginseng in Influenza and COVID-19 Management An Introduction to Ginseng Processing and Types of Ginseng Wild Ginseng and Cultivated Ginseng Major Benefits of Ginseng Functions and Use of Ginseng Global Market Prospects & Outlook Asian Ginseng Leads the Global Market Supplements Emerge as Major End-Use Market for Ginseng Asian Economies at the Forefront of Market Growth Ginseng Production Worldwide: Overview Global Ginseng Production (in Thousand Tons) by Country Competition World Brands Recent Market Activity MARKET TRENDS & DRIVERS Consumer Focus on Health and Wellness to Boost Popularity of Adaptogens, Favoring Demand for Ginseng Global Adaptogens Market by Source (in %) for 2020 Trends Towards Plant-Based Products Amidst Rising Health Awareness Fuels Market Prospects Rising Prominence of Ginseng as Functional Food Ingredient to Boost Market Growth Rising Sales of Functional Foods and Drinks to Boost Ginseng Demand: Global Functional Foods & Beverages Sales in US$ Billion for 2020 and 2027 Rising Health Consciousness Enhances Role of Ginseng in Natural Dietary Supplements Global Dietary Supplements Market Size (in US$ Billion) for the Years 2019, 2022 and 2025 Ginseng Supplements for Energy Boost Potential Role of Ginseng in Weight Management Products Obesity Prevalence Rate (%) in Select Countries for the Years 2019 and 2030P Average Per Capita Annual Health Expenditure (In US$) due to Obesity Potential Benefits of Ginseng in Treatment of Chronic Diseases Boosts Usage Proven Health Benefits of Ginseng Rising Prevalence of Lifestyle & Chronic Diseases Widens Prospects Hypertension Prevalence (%) Worldwide by Region in Male and Females Aged 25+ Years World Diabetes and Population Statistics (2019, 2030 & 2045) Fatalities by Heart Conditions: Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others Ginseng: A Traditional Ingredient in Various Medicinal Preparations Ginseng Dietary Supplement Finds Interest as Immune-Modulator Aging Human Diseases Ginseng's Promising Role in Neurological Disorders KIST Develops a Novel Microwave-based Method for Red Ginseng Processing, for Treatment of Lung Cancer Rising Consumer Awareness about Benefits of Ginseng Consumption Fuels Use in Food Products Growing Demand for Ginseng in Cosmetics and Personal Care Sectors Increased Spending on Natural and Organic Personal Care & Cosmetic Products Propels Market Growth Anti-Aging Benefits of Ginseng Propels Growth in the Cosmetics Industry Expanding Anti-Aging Products Market Bodes Well for Ginseng: Global Anti-Aging Cosmetics Market for the Years 2018, 2020, 2022 and 2024 Growing Preference for Natural Products Boosts Demand for American Ginseng Different Methods to Grow American Ginseng Growing Wild-simulated American Ginseng American Ginseng Production Suffers Due to Overharvesting Trade Wars and Pandemic Impacts American Ginseng Farmers Ginseng Extract Market: Poised for High Growth Concerns Over Side Effects Impede Wider Uptake FOCUS ON SELECT PLAYERS (Total 123 Featured) Amorepacific Corporation Frederic M France, S.A. G & G Century (M) Sdn Bhd Ethical Naturals, Inc. Canada Royal Enoch Phytomedicine Limited Captek Softgel International Inc. GOH JOO HlN Pte. Limited Blooms The Chemist Management Services Limited Cellchem Pharmaceuticals Inc. ATC Healthcare International Corporation Euro Enterprise Bob Ginseng Enzo Bevande Fine Korea Company Limited Cardinal Hk Company Limited For more information about this report visit About ResearchAndMarkets.com ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Media Contact: Research and Markets Laura Wood, Senior Manager [email protected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Logo: SOURCE Research and Markets

DUBLIN, March 27, 2023 /PRNewswire/ -- The "Lipid Nanoparticles in Drug Delivery: Intellectual Property Landscape" report has been added to ResearchAndMarkets.com's offering. This report features an extensive study of some of the key historical and contemporary intellectual property (IP) documents (featuring granted patents, patent applications and other documents), describing the various applications of lipid nanoparticles in drug delivery. The insights generated in this report have been presented across two deliverables, namely a MS Excel workbook and a MS PowerPoint deck, summarizing the ongoing activity in this domain. Key inclusions are briefly described below: Low drug solubility and its corresponding impact on bioavailability have remained a primary cause of concern with several marketed as well as clinical stage drugs. According to the Journal of Analytical and Pharmaceutical Research, 70% of the 50 drugs approved by the USFDA in 2021 were poorly soluble. Moreover, approximately 40% of marketed pharmacological products and close to 90% of drug candidates under development, have been associated with solubility and / or permeability issues, resulting in poor bioavailability. It is worth noting that, every year, a large number of drugs fail to reach the market due to poor bioavailability and issues associated with aqueous solubility. As a result, the industry is actively seeking various tools / methods to mitigate this challenge. Amongst the various approaches for bioavailability enhancement of therapeutic interventions, lipid nanoparticles (LNPs) and other lipidic excipients have gained sufficient attention from drug developers owing to their ability to act as drug carriers for complex, albeit highly promising therapeutics. Many studies have indicated that lipid-based formulations are capable of solving the complex drug delivery challenges currently faced by this industry. This can be attributed to the versatility of such molecules in terms of structure and functionality, as well as their ability to enhance the solubility and bioavailability of poorly water-soluble (hydrophobic) drugs. It is worth highlighting that, currently, lipid nanoparticles / lipids are the most commonly used drug delivery systems, specifically for mRNA therapeutics and vaccines. In fact, LNPs have been used in several mRNA-based COVID-19 vaccines to encapsulate and deliver genetic material to the target cells. As a result, the demand for lipid nanoparticles as drug delivery systems has grown considerably over the years. Presently, several studies are underway to evaluate the potential of next-generation lipid nanoparticles as effective drug delivery systems, aiming to enable the development of therapies with high efficacy and bioavailability. Given the extensive research activity, the intellectual capital related to the use of LNPs in drug delivery has also grown over time. Therefore, it is important to keep track of both pockets of innovation and key areas of improvement for stakeholders to remain competitive in this upcoming field of the healthcare domain. This report captures some of the key R&D trends and provides competitive intelligence on intellectual property related to lipid nanoparticles and their applications in drug delivery. Overall Intellectual Property Landscape An analytical perspective of the various patents and affiliated IP documents that have been published related to lipid nanoparticles in drug delivery, since 1977. An in-depth analysis of published IP documents, representing unique patent families across various global jurisdictions, featuring insightful inferences related to both historical and recent R&D trends within this niche, yet rapidly evolving segment of the biotechnology and pharmaceutical industry. Popular / Relevant Prior Art Search Expressions An examination of IP literature, shortlisting key words and phrases used to describe lipid nanoparticles in drug delivery. The analysis also includes details on the historical use of the aforementioned terms across different IP filings, key affiliated terms (which can be used to identify other relevant IP search terms and establish relationships between prior art search expressions), and other related trends. Patent Valuation Analysis A competitive benchmarking and valuation analysis of the key members of unique patent families captured in the report, taking into consideration important parameters, such as type of IP document, year of application, time to expiry, number of citations and jurisdiction (factoring in value associated with the gross domestic product (GDP) of a particular region). Patentability and Freedom to Operate A systematic approach to identify relevant areas of innovation by analyzing published IP documents (representative of unique patent families), by defining the uniqueness of patented / patent pending innovations, in order to assess the scope of patentability in this domain, and pinpoint jurisdictions wherein new and / or modified claims may be filed without infringing on existing IP. Analysis of Patent Applications A detailed summary of the various patent applications (representative of unique patent families) that were filed across different jurisdictions and their relative value in the IP ecosystem. The analysis classified the intellectual capital in terms of type of innovation and the innovation (such as a product class, enabling technologies or method of use), thereby, offering the means to identify active arenas of research and assess innovation-specific IP filing trends. Analysis of Granted Patents An analysis of the granted patents (representative of unique patent families) across different global jurisdictions and their relative value in the IP ecosystem. The analysis also features a meaningful classification system, segregating granted IP into relevant categories (namely type of innovation and innovation) to help develop a detailed perspective on the diversity of intellectual capital (having marketing exclusivity) related to lipid nanoparticles in drug delivery, and the assessing likelihood for innovators to enter into promising research areas. Pockets of Innovation and White Spaces An insightful analysis of the various CPC codes used in published IP literature (representative of unique patent families) and their affiliated families, offering the means to identify historical and existing pockets of innovation (based on the functional area / industry described by the elaborate and systematic IP classification approach, mentioned earlier); the analysis also features a discussion on prevalent white spaces (based on type of innovation and innovation) in this field of research. Claim Analysis One of the objectives of the report was to analyze and summarize key inferences from the independent claims mentioned in granted, active patents (representative of unique patent families) in the dataset. Using a systematic segregation approach, we have analyzed trends associated with the preamble, type of patent (product patent or method patent), type of claim (open ended claim or closed ended claim) and key elements of a claim (individual aspects of an innovation that are covered in a singular claim). Key Topics Covered: Excel Deliverable 1. Research Notes 2. Summary Dashboard A. Overall Intellectual Property Landscape B. Intellectual Property Landscape (Grouped by Simple Families) C. Key Prior Art Search Expressions D. Key Trends related to Patent Applications (featuring Patentability and Freedom to-Operate) E. Key Trends related to Granted Patents (featuring Patentability and Freedom-to-Operate) F. Claims Analysis G. Key CPC Symbols H. Key Applicants 3. Overall Intellectual Property Landscape Dataset 4. Prior Art Search Expressions (Keyword Analysis) 5. Patent Applications Dataset 6. Granted Patents Dataset 7. Claims Analysis 8. Key Applicants Analysis 9. CPC Analysis 10. Appendix I: Pivot Tables 11. Appendix II: Country / Geography Codes 12. Appendix III: Innovation Categories PowerPoint Deliverable 1. Context 2. Project Approach 3. Project Objectives 4. Executive Summary 5. Lipid Nanoparticles in Drug Delivery 5.1. Overview 5.2. Introduction to Lipid Nanoparticles 5.3. Advantages and Applications of Lipid Nanoparticles in Pharmaceutical Industry 5.4. Future Perspectives 6. Overall Intellectual Property Landscape 6.1. Overview 6.2. Analysis of Simple Patent Families 6.3. Key Innovation Categories 6.4. Insights from Patent Applications 6.5. Insights from Granted Patents 7. Key Prior Art Search Expressions 7.1. Overview 7.2. Analysis of Prior Art Search Expressions 8. Intellectual Property Valuation Analysis 8.1. Valuation Overview 8.2. Analysis of Individual Value Ranks 8.2.1. Rank 1 IP Documents 8.2.2. Rank 2 IP Documents 8.2.3. Rank 3 IP Documents 8.2.4. Rank 4 IP Documents 8.2.5. Rank 5 IP Documents 8.3. Concluding Remarks 8.4. List of Rank 1 IP Documents 9. Analysis of Patent Applications 9.1. Overview 9.2. Relative Valuation of Patent Applications 9.3. Patentability and Freedom-to-Operate 10. Analysis of Granted Patents 10.1. Overview 10.2. Relative Valuation of Grated Patents 10.3. Patentability and Freedom-to-Operate 10.4. Analysis of Patent Claims (Granted Active Patents) 11. Key Applicants 11.1. Overview 11.2. Analysis of Key Applicants 12. Pockets of Innovation and White Spaces 12.1. Overview 12.2. Pockets of Innovation 12.3. White Spaces 12.4. Concluding Remarks 13. Future Outlook 13.1. Lipid Nanoparticles in Drug Delivery: IP Filing Growth Trends 13.2. Relevance of IP for Business Development and Growth 13.3. Contemporary Sentiments and Predictions 13.4 Anticipated Future Developments and Trends 14. Appendices Companies Mentioned Aarhus University 3M Innovative Properties Abbott Abcombi Biosciences ABIONYX Pharma AC BioScience AC Immune Academia Sinica Access Pharma ACM Biolabs ACT Therapeutics Acuitas Therapeutics Adjuvantix Aduro BioTech Advanced BioScience Laboratories (ABL) Advanced Cardiovascular Systems Advanced Inhalation Research Advaxis Aegis Therapeutics AfGin Pharma Agency for Science, Technology and Research (A*STAR) AGENE Research Institute Agenus Agilent Technologies AgoneX Biopharmaceuticals AgResearch AgroSource Akagera Medicines Albany Medical College Albert Einstein College of Medicine Albumedix Alcon Alcyone Therapeutics Aleph Therapeutics Alexion Pharmaceuticals Alloplex Biotherapeutics Almac Discovery Alnylam Pharmaceuticals Alpharma ALSATECH Altea Therapeutics Altus Pharmaceuticals ALZA Corporation Alzeca Biosciences Amorepacific Corporation Amur Pharmaceuticals Ancora Pharmaceuticals Angarus Therapeutics Angioslide And Many More Companies! For more information about this report visit About ResearchAndMarkets.com ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Media Contact: Research and Markets Laura Wood, Senior Manager [email protected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Logo: SOURCE Research and Markets

LAS VEGAS, Nev.--( BUSINESS WIRE )-- ASLEEP , a sleep technology company, announced that it will unveil the blueprint for an individually tailored sleep ecosystem based on its unrivaled AI-based sleep tracking technology at the CES 2023. Through AI technology that tracks sleep stages through breathing sounds during sleep, ASLEEP provides extensive sleep-related services. ASLEEP’s technology can detect sleep stages in any environment using only microphone-equipped devices such as smartphones, smart TVs, or speakers. ASLEEP’s sleep detection technology reports the highest accuracy without wearing wearable devices such as smartwatches. It can detect REM sleep, non-REM sleep, and wake state on average 15% more accurately than industry-leading smartwatches. ASLEEP’s technology has been recognized as a solution optimized for a real environment. It works in various environments, including home environments, and performs well regardless of age, sex, and gender. In addition, ASLEEP has published a novel method of detecting sleep stage and sleep-related respiratory events in real-time in various academic journals. ASLEEP’s unrivaled accuracy and innovativeness are acknowledged at CES 2023. ASLEEP is expected to lead the SleepTech ecosystem as it seized the largest booth amongst SleepTech companies within three years of its establishment. ASLEEP will showcase Sleeptrack API, the aggregate of ASLEEP’s proprietary technology, and present a new sleep environment in collaboration with various IT and home appliances companies at CES 2023. Sleeptrack API can measure sleep quality and link this information to products and services from other companies, and create a sustainable service that improves customers' sleep quality. ASLEEP will introduce products that combine beauty and health by tackling futuristic sleep environment establishment and lifestyle improvement in collaboration with Amorepacific and global IT companies. Dongheon Lee, ASLEEP CEO, stated, “Dream your Next Business with ASLEEP. ASLEEP focuses on not only directly applying our technology, like our collaboration with global IT companies, but we also help other companies indirectly related to the sleep market to dive into the market using our advanced technology.” While ASLEEP has been making full-fledged advances in the global market, Clete A. Kushida, Professor and Director of the Stanford Center for Human Sleep Research, will join ASLEEP in the CES showcase. ASLEEP plans to begin collaborative research with Stanford University Sleep Center to prove its robust performance across different ethnic groups.